Clinical trial
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
NCT02935153 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
- Lead sponsor
- Southwest Hospital, China
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- October 31, 2020
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.